Biomarkers Industry Analysis

Biomarkers

Change currency
Stakeholder Opinions: Biomarkers in Rheumatology (DAT17469)
Awaiting the next step towards personalized medicineIntroduction The growing recognition from companies of the applied benefits from biomarkers in rheumatology has spurred commercial interest in this field. Despite the lack of major advancements, the hope remains that...
Dec 2009£2,360€2,800$3,800
Advances in the Use of Biomarkers in Biochip and Microarray Testing (RBI00351)
Innovative technologies, growth opportunities and the future market outlookMicroarrays and biochips are small devices capable of detecting and measuring large numbers of biomarkers simultaneously. Although microarrays have been in research use for over a decade it is only...
Oct 2009£2,380€2,824$3,835
Biomarkers - Advanced Technologies and Global Market (MAK00016)
2009 - 2014The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker...
Sep 2009£2,885€3,423$4,650
CNS Biomarkers: Players, products and prospects (Volume II) (ESP00706)
Part of Espicom's new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the CNS biomarker sector, along with a critical assessment of the...
Aug 2008£595€706$958
Cardiovascular Biomarkers: Players, products and prospects (Volume III) (ESP00564)
Part of Espicom's new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the cardiovascular biomarker sector, along with a critical assessment of the...
Aug 2008£595€706$958
Cancer Biomarkers: Players, products and prospects (Volume I) (ESP00559)
Part of Espicom's new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the cancer biomarker sector, along with a critical assessment of the...
Aug 2008£595€706$958
Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects (ESP00558)
Over 350 information-packed pages providing Forecasts of biomarker market value and therapy share to 2015 Detailed analysis of the products and potential of companies active in each sector 40 Cancer 29 CNS 34 Cardiovascular Major...
Aug 2008£1,495€1,774$2,408
Cancer Biomarkers (IPR00013)
Adoption Is Driving GrowthAggressive adoption of cancer biomarkers will accelerate the growth of commercial markets for these products. This new report offers in-depth analysis of: The current cancer biomarker products, applications, and markets Key validation...
Jul 2008£2,330€2,764$3,750
Convergence of Biomarkers and Diagnostics, The (RBI00214)
Therapy Area Analyses, Key Products and Future TrendsIn recent years, there have been concerted efforts to enhance the precision of disease diagnosis and monitoring as the hetrogeneity of conditions becomes increasingly understood. Targeting broad patient populations in...
Apr 2008£2,380€2,824$3,835
Biomarkers: A Market Briefing (KAL00038)
A Market BriefingPersonalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers are anatomic, physiologic, biochemical...
Jan 2007£1,240€1,471$1,995
Biomarkers (BCC00167)
The Expanding Global MarketBiomarker-based tests have been in existence for over a few decades now but their relevance to drug development and diagnostics applications in particular has gained momentum only recently. This is...
Jan 2007£2,540€3,014$4,088
Cancer Biomarkers (DAT19510)
Enhancing diagnostic, therapeutic and developmental strategiesIntroduction The current focus on biomarker discovery is a result of an improved understanding of the biologic basis for carcinogenesis. The increasing number of potential drug targets and a plethora of...
May 2006£1,365€1,620$2,195